Calidi Biotherapeutics, Inc.

CLDI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Mar 10, 2025
8-K/A Feb 10, 2025
EFFECT Feb 7, 2025
CORRESP Feb 6, 2025
424B5 Feb 5, 2025
8-K Feb 5, 2025
8-K Jan 28, 2025
UPLOAD Jan 15, 2025
S-3 Jan 10, 2025
8-K Jan 10, 2025
8-K Jan 10, 2025
424B5 Jan 10, 2025
424B5 Jan 8, 2025
4 Jan 3, 2025
4 Jan 3, 2025
EFFECT Dec 27, 2024
CORRESP Dec 26, 2024
4 Dec 18, 2024
UPLOAD Dec 17, 2024
S-1 Dec 12, 2024
424B5 Nov 29, 2024
8-K Nov 18, 2024
8-K Nov 15, 2024
424B5 Nov 15, 2024
SC 13G/A Nov 14, 2024 CALIDI BIOTHERAPEUTICS, INC.
← Newer Page 5 of 17 · 403 filings Older →